Centro de Pesquisas Oncologicas

Site:	Centro de Pesquisas Oncologicas
Address:
City:	Florianopolis
State:
Zip:
Country:	Brazil

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	A Phase 3 Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib (INSIGHT)	Recruiting	Active	Ripretinib	NCT05734105
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785